Drug ID: | NPD7832 |
Drug Name: | |
Molecular Formula: | C33H47NO3 |
Canonical SMILES: | CCN(Cc1ccc(c(c1)OC)OCC[C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2[C@H](C)Cc2c1ccc(c2)O)CC |
Standard InCHI: | InChI=1S/C33H47NO3/c1-6-34(7-2)21-23-8-13-30(31(19-23)36-5)37-17-15-25-9-12-29-32-22(3)18-24-20-26(35)10-11-27(24)28(32)14-16-33(25,29)4/h8,10-11,13,19-20,22,25,28-29,32,35H,6-7,9,12,14-18,21H2,1-5H3/t22-,25-,28-,29+,32-,33-/m1/s1 |
Standard InCHIKey: | OHCPNHFLPCVWRG-MWSJHZLTSA-N |
Max Developmental Stage: | Clinical (unspecified phase) |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DNCL002607 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | 9874874 |
ChEBI | |
CAS Number |
Molecular Weight | 505.36 |
ALogP | 0.9346 |
MLogP | 4.65 |
XLogP | 9.768 |
HDA | 1 |
HBD | 1 |
Rotatable Bonds | 15 |
TPSA | 41.93 |
RO5 Violation | 1 |